Paul Mahon
General Counsel presso UNITED THERAPEUTICS CORPORATION
Patrimonio netto: 8 M $ in data 31/03/2024
Profilo
Paul A.
Mahon is currently the Co-Managing Director at Unither Therapeutik GmbH.
He is also currently serving as the Secretary, Executive VP & General Counsel at United Therapeutics Corp.
and Miromatrix Medical, Inc. In the past, he worked as a Director at SteadyMed Ltd.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
04/04/2024 | 36 710 ( 0.08% ) | 8 M $ | 31/03/2024 |
Posizioni attive di Paul Mahon
Società | Posizione | Inizio |
---|---|---|
UNITED THERAPEUTICS CORPORATION | General Counsel | 01/01/2001 |
MIROMATRIX MEDICAL INC. | General Counsel | 11/12/2023 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Chief Executive Officer | - |
Precedenti posizioni note di Paul Mahon
Società | Posizione | Fine |
---|---|---|
STEADYMED LTD | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
MIROMATRIX MEDICAL INC. | Health Technology |
Aziende private | 2 |
---|---|
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
- Borsa valori
- Insiders
- Paul Mahon